Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotarix dose-ranging efficacy and safety in infants
NCT00429481Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2001
- Primary completion
- Apr 2003
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 2 trial of human rotavirus vaccine, live attenuated in rotavirus gastroenteritis, sponsored by GSK. Started Jan 2001; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00429481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429481.